Date: 2016-02-04
Type of information: Collaboration agreement
Compound: tissue bank for cancer research
Company: Indivumed (Germany) The University of Rochester Medical Center (USA - NY)
Therapeutic area: Cancer - Oncology
Type agreement: R&D collaboration
Action mechanism:
Disease: Cancer
Details: * On February 4, 2016, the University of Rochester Medical Center announced it’s collaborating with Indivumed, a Germany-based company, to establish a bank of human tissues and tumor samples that are expertly preserved and stored for use in cancer research. The URMC signed a three-year agreement with Indivumed. Approximately 15 other research institutions have formed similar partnerships with the company—including Georgetown University’s Lombardi Comprehensive Cancer Center in Washington, D.C., the Geisinger Health System in Pennsylvania, and several medical centers in Europe—enabling a worldwide network for researchers to access the biological specimens. The program starts immediately, and includes collection of many types of cancerous tissues such as
pancreatic, colorectal, lung, and breast. Patients will be asked to consent to having their tissue included in the bank for research purposes.
Financial terms: Financial details were not disclosed.
Latest news:
